ALLERGIC ASTHMA
Clinical trials for ALLERGIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC ASTHMA trials appear
Sign up with your email to follow new studies for ALLERGIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma drug trial seeks to tame severe allergies
Disease control Recruiting nowThis study is testing an investigational drug called FB825 to see if it can help control moderate-to-severe allergic asthma in adults. About 100 participants will receive either the drug or a placebo via IV infusion over 24 weeks, while continuing their standard inhaler medicatio…
Matched conditions: ALLERGIC ASTHMA
Phase: PHASE2 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Fewer shots for cat allergies? new injection method tested
Disease control Recruiting nowThis study is testing a new way to treat cat allergies called intralymphatic immunotherapy (ILIT). Instead of about 50 shots over 3 years, this method uses just 3-4 injections directly into a lymph node. Researchers want to see if this approach is safe and how it affects the immu…
Matched conditions: ALLERGIC ASTHMA
Phase: PHASE1, PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New asthma shot aims to tame severe allergies and prevent Flare-Ups
Disease control Recruiting nowThis study is testing an investigational injection called LP-003 for adults with moderate to severe allergic asthma that isn't fully controlled with standard inhalers. The main goal is to see if the injection can reduce the number of serious asthma flare-ups and improve day-to-da…
Matched conditions: ALLERGIC ASTHMA
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Cheaper copycat drug put to the test: does it work as well?
Disease control Recruiting nowThis study is observing patients who are already doing well on a specific biologic drug for severe asthma or chronic hives. Their doctors have decided to switch them to a new, similar version called a biosimilar. The main goal is to see if patients remain well-controlled and sati…
Matched conditions: ALLERGIC ASTHMA
Sponsor: Celltrion HealthCare France • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists hunt for early warning signs of deadly thunderstorm asthma
Knowledge-focused Recruiting nowThis study aims to find biological markers that can predict who is at high risk for severe asthma attacks during spring pollen seasons and thunderstorms. Researchers will track 530 adults with hay fever in Australia over two years, monitoring their symptoms and testing their bloo…
Matched conditions: ALLERGIC ASTHMA
Phase: NA • Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC